Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT06445335
NCT06445335Active, not recruitingNot Applicable

The Prevalence of Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus Patients Followed at Ziekenhuis Oost-Limburg, Genk, Belgium

Ziekenhuis Oost-Limburg2 sites in 1 country385 target enrollmentStarted: March 1, 2019Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
385
Locations
2
Primary Endpoint
Prevalence of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes mellitus (T2DM) patients
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

To determine the prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM).

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •≥ 18 years of age
  • •Having type 2 diabetes mellitus (T2DM)
  • •Written informed consent obtained

Exclusion Criteria

  • •Excessive alcohol use
  • •Exclusion of other causes of liver disease and secondary causes of steatosis

Outcomes

Primary Outcomes

Prevalence of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes mellitus (T2DM) patients

Time Frame: Baseline

To determine the prevalence of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes mellitus (T2DM) patients followed at the department of Endocrinology in Ziekenhuis Oost-Limburg (ZOL), Genk, Belgium by means of FibroScan measurements.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Ziekenhuis Oost-Limburg
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Unknown
Not Applicable
Prevalence of Metabolic Liver Diseases in Patients With Type 1 Diabetes MellitusNon-alcoholic Fatty Liver DiseaseGlycogen HepatopathyLiver DiseasesType 1 Diabetes
NCT05054712Consorci Sanitari de l'Alt Penedès i Garraf250
Recruiting
Not Applicable
Prevalence of NAFLD in T1DM PatientsNAFLDFatty Liver, NonalcoholicType 1 Diabetes
NCT06445361Ziekenhuis Oost-Limburg138
Active, not recruiting
Not Applicable
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 DiabetesNonalcoholic Fatty LiverNonalcoholic SteatohepatitisFibrosis, LiverCirrhosis, LiverType 1 Diabetes
NCT04595474Joslin Diabetes Center533
Completed
Not Applicable
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver BiopsyFatty Liver
NCT01100398Brooke Army Medical Center400
Not yet recruiting
Not Applicable
Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University HospitalNAFLD - Nonalcoholic Fatty Liver Disease
NCT06601361Assiut University112